DOI QR코드

DOI QR Code

Hepatotoxic Effects of 1-Furan-2-yl-3-pyridin-2-yl-propenone, a New Anti-Inflammatory Agent, in Mice

  • Published : 2009.07.31

Abstract

1-Furan-2-yl-3-pyridin-2-yl-propenone (FPP-3) has recently been synthesized and characterized to have an anti-inflammatory activity through the inhibition of the production of nitric oxide. In the present study, adverse effects of FPP-3 on hepatic functions were determined in female BALB/c mice. When mice were administered with FPP-3 at 125, 250 or 500 mg/kg for 7 consecutive days orally, FPP-3 significantly increased absolute and relative weights of liver with a dose-dependent manner. In addition, FPP-3 administration dramatically increased the hepatotoxicity parameters in serum at 500 mg/kg, in association of hepatic necrosis. FPP-3 significantly induced several phase I enzyme activities. To elucidate the possible mechanism(s) involved in FPP-3 induced hepatotoxicity, we investigated the hepatic activities of free radical generating and scavenging enzymes and the level of hepatic lipid peroxidation. FPP-3 treatment significantly elevated the hepatic lipid peroxidation, measured as the thiobarbituric acid-reactive substance, and the activity of superoxide dismutase. Taken together, the present data indicated that reactive oxygen species might be involved in FPP-3-induced hepatotoxicity.

Keywords

References

  1. Aebi, H. (1984). Catalase in vitro. Methods Enzymol. 105, 121-126 https://doi.org/10.1016/S0076-6879(84)05016-3
  2. Blank, J. A., Tucker, A. N., Sweatlock, J., Gasiewicz, T. A. and Luster, M. I. (1987). ${\alpha}$-Naphthoflavone antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin induced murine ethoxyresorufin O-deethylase activity and immunosuppression. Mol. Pharmacol. 32, 168-172
  3. Carlberg, I. and Mannervik, B. (1975). Purification and characterization of the flavoenzyme glutathione reductase from rat liver. J. Biol. Chem. 250, 5475-5480
  4. Gonzalez, F. J. (2005). Role of cytochromes P450 in chemical toxicity and oxidative stress: studies with CYP2E1. Mutat. Res. 569, 101-110 https://doi.org/10.1016/j.mrfmmm.2004.04.021
  5. Hayes, J. D. and McLellan, L. I. (1999). Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free Radic. Res. 31, 273-300 https://doi.org/10.1080/10715769900300851
  6. Hwang, Y. P., Han, E. H., Choi, J. H., Kim, H. G., Lee, K. J., Jeong, T. C., Lee, E. S. and Jeong, H. G. (2008). Chemopreventive effects of furan-2-yl-3-pyridin-2-yl-propenone against 7,12-dimethylbenz[a]anthracene-inducible genotoxicity. Toxicol. Appl. Pharmacol. 228, 343-350 https://doi.org/10.1016/j.taap.2007.12.018
  7. Jahng, Y., Zhao, L. X., Moon, Y. S., Basnet, A., Kim, E. K., Chang, H. W., Ju, H. K., Jeong, T. C. and Lee, E. S. (2004). Simple aromatic compounds containing propenone moiety show considerable dual COX/5-LOX inhibitory activities. Bioorg. Med. Chem. Lett. 14, 2559-2562 https://doi.org/10.1016/j.bmcl.2004.02.099
  8. Koop, D. R. (1986). Hydroxylation or p-nitrophenol by rabbit ethanol inducible cytochrome P-450 isozyme 3A. Mol. Pharmacol. 29, 399-404
  9. Kyle, M. E., Miccadei, S., Nakae, D. and Farber, J. L. (1987). Superoxide dismutase and catalase protect cultured hepatocytes from the cytotoxicity of acetaminophen. Biochem. Biophys. Res. Commun. 149, 889-896 https://doi.org/10.1016/0006-291X(87)90491-8
  10. Lamba, J. K., Lin, Y. S., Schuetz, E. G. and Thummel, K. E. (2002). Genetic contribution to variable human CYP3Amediated metabolism. Adv. Drug Deliv. Rev. 54, 1271-1294 https://doi.org/10.1016/S0169-409X(02)00066-2
  11. Larrea, E., Garcia, N., Qian, C., Civeira, M. P. and Prieto, J. (1994). Enhanced expression of TNF${\alpha}$ in patients with primary biliary cirrhosis. Int. Hepatol. Commun. 2, 6-13 https://doi.org/10.1016/0928-4346(94)90003-5
  12. Lee, E. S., Ju, H. K., Moon, T. C., Lee, E., Jahng, Y., Lee, S. H., Son, J. K., Baek, S. H. and Chang, H. W. (2004). Inhibition of nitric oxide and tumor necrosis factor-${\alpha}$ (TNF-${\alpha}$) production by propenone compound through blockade of nuclear factor (NF)-$_KB$ activation in cultured murine macrophages. Biol. Pharm. Bull. 27, 617-620 https://doi.org/10.1248/bpb.27.617
  13. Lee, E. S., Park, B. C., Paek, S. H., Lee, Y. S., Basnet, A., Jin, D. Q., Choi, H. G., Yong, C. S. and Kim, J. A. (2006). Potent analgesic and anti-inflammatory activities of 1-furan-2-yl-3-pyridin-2-yl-propenone with gastric ulcer sparing effect. Biol. Pharm. Bull. 29, 361-364. https://doi.org/10.1248/bpb.29.361
  14. Lee, S. K., Kim, J. H., Seo, Y. M., Kim, C. H., Kang, M. J., Jeong, H. G., Lee, E. S. and Jeong, T. C. (2008). In vitro characterization of the enzymes involved in the metabolism of 1-furan-2-yl-3-pyridin-2-yl-propenone, an anti-inflammatory propenone compound. Arch. Pharm. Res. 31, 764-770 https://doi.org/10.1007/s12272-001-1224-3
  15. Lee, S. K., Lee, D. J., Jeong, H., Bista, S. R., Kang, M. J., Lee, E. S., Son, J. K., Nam, D. H., Chang, H. W., Lee, S. H., Jahng, Y. and Jeong, T. C. (2007). Hepatotoxic and immunotoxic effects produced by 1,3-dibromopropane and its conjugation with glutathione in female BALB/c mice. J. Toxicol. Environ. Health A. 70, 1381-1390 https://doi.org/10.1080/15287390701434489
  16. Lowry, O. H., Rosenbrough, N. J., Farr, A. L. and Randall, R. J. (1951). Protein measurement with the folin phenol reagent. J. Biol. Chem. 193, 265-275
  17. Lubet, R. A., Meyer, R. T., Cameron, J. W., Nims, R. W., Burke, M. D., Wolff, J. and Guengerich, F. P. (1985). Dealkylation of pentoxyresorufin: a rapid and sensitive assay for measuring induction of cytochrome(s) P-450 by phenobarbital and other xenobiotics in the rat. Arch. Biochem. Biophys. 238, 43-48 https://doi.org/10.1016/0003-9861(85)90138-9
  18. Luster, M. I., Portier, C., Pait, D. G., White, K. L. Jr., Gennings, C., Munson, A. E. and Rosenthal, G. J. (1992). Risk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests. Fund. Appl. Toxicol. 18, 200-210 https://doi.org/10.1016/0272-0590(92)90047-L
  19. Luster, M. I., Simeonova, P. P., Gallucci, R. and Matheson, J. (1999). Tumor necrosis factor ${\alpha}$ and toxicology. Crit. Rev. Toxicol. 29, 491-511 https://doi.org/10.1080/10408449991349258
  20. Marklund, S. and Marklund, G. (1974). Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur. J. Biochem. 47, 469-474 https://doi.org/10.1111/j.1432-1033.1974.tb03714.x
  21. Maser, E. (1995). Xenobiotic carbonyl reduction and physiological steroid oxidoreduction. The pluripotency of several hydroxysteroid dehydrogenases. Biochem. Pharmacol. 49, 421-440 https://doi.org/10.1016/0006-2952(94)00330-O
  22. Nash, T. (1953). The colorimetrical estimation of formaldehyde by means of the Hantzsch reaction. Biochem. J. 55, 416-421 https://doi.org/10.1042/bj0550416
  23. Nicholls, D. G. and Budd, S. L. (2000). Mitochondria and neuronal survival. Physiol. Rev. 80, 315-360 https://doi.org/10.1152/physrev.2000.80.1.315
  24. Ohkawa, H., Ohishi, N. and Yagi, K. (1979). Assay for lipid peroxide in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95, 351-358 https://doi.org/10.1016/0003-2697(79)90738-3
  25. Paglia, D. E. and Valentine, W. N. (1967). Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 70, 158-169
  26. Roy, A., Soni, G. R., Kolhapure, R. M., Banerjee, K. and Patki, P. S. (1992). Induction of tumour necrosis factor ${\alpha}$ in experimental animals treated with hepatotoxicants. Indian J. Exp. Biol. 30, 696-700.
  27. Shanmugam, S., Lee, E. S., Jeong, T. C., Yong, C. S., Choi, H. G., Woo, J. S. and Yoo, B. K. (2008). The effects of 1-furan-2-yl-3-puridine-2-yl-propenone on pharmacokinetic parameters of warfarin. Arch. Pharm. Res. 30, 898-904 https://doi.org/10.1007/BF02978843
  28. Shanmugam, S., Lee, E. S., Lee, S. K., Jeon, T. W., Yong, C. S. and Yoo, B. K. (2006). The effect of 1-furan-2-yl-3-puridine- 2-yl-propenone on pharmacokinetic parameters of theophylline. Biol. Pharm. Bull. 29, 1282-1285 https://doi.org/10.1248/bpb.29.1082
  29. Simeonova, P. P., Gallucci, R. M., Hulderman, T., Wilson, R., Kommineni, C., Rao, M. and Luster, M. I. (2001). The role of tumor necrosis factor-${\alpha}$ in liver toxicity, inflammation, and fibrosis induced by carbon tetrachloride. Toxicol. Appl. Pharmacol. 177, 112-120 https://doi.org/10.1006/taap.2001.9304
  30. Szotakova, B., Baliharova, V., Lamka, J., No.inova, E., Wsol, V., Velik, J., Machala, M., Ne.a, J., Sou.ek, P., .usova, S. and Skalova, L. (2004). Comparison of in vitro activities of biotransformation enzymes in pig, cattle, goat and sheep. Res. Vet. Sci. 76, 43-51 https://doi.org/10.1016/S0034-5288(03)00143-7
  31. Thapa, D., Lee, J. S., Park, M. A., Cho, M. Y., Park, Y. J., Choi, H. G., Jeong, T. C. and Kim, J. A. (2009). Inhibitory effects of clotrimazole on TNF-a-induced adhesion molecule expression and angiogenesis. Arch. Pharm. Res. 32, 593-603 https://doi.org/10.1007/s12272-009-1416-6
  32. Wong, G. H., Elwell, J. H., Oberley, L. W. and Goeddel, D. V. (1989). Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell 58, 923-931 https://doi.org/10.1016/0092-8674(89)90944-6
  33. Yu, B. P. (1994). Cellular defenses against damage from reactive oxygen species. Physiol. Rev. 74, 139-162 https://doi.org/10.1152/physrev.1994.74.1.139
  34. Zhao, J., Chatterjee, M. L., Sharma, Y. and Agarwal, R. (2000). Inhibitory effect of a flavonoid antioxidant silymarin on benzoyl peroxide-induced tumor promotion, oxidative stress and inflammatory responses in SENCAR mouse skin. Carcinogenesis. 21, 811-816 https://doi.org/10.1093/carcin/21.4.811

Cited by

  1. Palladium-catalyzed oxidative heterocyclodehydration-alkoxycarbonylation of 3-yne-1,2-diols: a novel and expedient approach to furan-3-carboxylic esters vol.51, pp.13, 2010, https://doi.org/10.1016/j.tetlet.2010.01.054
  2. Immunotoxicological Investigation of 1-furan-2-yl-3-pyridin-2-yl-propenone in Female BALB/c Mice vol.17, pp.4, 2009, https://doi.org/10.4062/biomolther.2009.17.4.446